FDA and EMA Collaborate on Expandable Model for Rare Pediatric Drug Development

Drug Industry Daily
A A
The FDA and the European Medicines Agency released a draft joint plan Monday to support the development of pediatric treatments for Gaucher disease — an approach the agencies say can apply to rare diseases in general.

To View This Article:

Login

Subscribe To Drug Industry Daily